Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
about
Inhaled insulin: overview of a novel route of insulin administration.Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.Inhaled insulin--a new therapeutic option in the treatment of diabetes mellitus.Insulin analogues and other developments in insulin therapy for diabetes.Inhaled insulin for the treatment of diabetes: projects and devices.Alternative routes of insulin delivery.Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes.Diabetes therapy trials with inhaled insulin.The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.First approved inhaled insulin therapy for diabetes mellitus.AIR Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes.Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).Evaluation of novel particles as pulmonary delivery systems for insulin in rats.Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.Novel non-invasive methods of insulin delivery.Newer devices and improved formulations of inhaled insulin.Can inhaled insulin be used for the treatment of diabetes mellitus?Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules.Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
P2860
Q33715395-A1014D1A-3BE3-4C7B-A692-2C2DB2610BAAQ34351640-287DA24F-45EE-496F-A68E-CFA13B064EE8Q35058109-76991270-8FEA-4B00-8EFE-540D5264C4E7Q35164710-EBA959FF-64EA-4ED8-9F94-A273CAE9EA75Q35183764-29FA933D-1C23-4651-BA04-AB19742D4832Q35591065-5CDE95B6-61A7-4210-AF4A-E35B948AA5A5Q35826982-5194A7B8-89D7-42FF-AA1E-B540BF19AABFQ35967358-A9F4F8E5-C895-4D26-85CB-B5DF0FE2E2BFQ36512554-AC603EA1-9DC5-4900-8564-EC15C2A2DBFAQ36535857-CA383F5D-9B82-459E-A8DF-93DE918BED98Q36690218-D7C3AE4E-7EB4-4D09-ABCD-A984159DD795Q36938359-A4C42FFF-81A9-482A-B996-B94BE7C755F5Q36964727-93CD6383-EBA7-458C-AC2D-967586A76885Q37362017-AE6B8E31-AAE9-4A58-A388-67A86987356EQ37407977-88CAA888-06D9-48C7-BB68-33FAC76ED0C8Q38055517-8382D9C7-8D43-4D18-9D14-3CC80CEED226Q38285092-0D96DF7A-828E-477B-88F5-0EE7919377A0Q42472493-32F5525A-DB22-4BDA-89D9-2E54147CEDD4Q44613023-E82BA47B-F313-4E41-BF9B-D2F9BABD2F52Q44705879-D752E883-98AB-4A54-BA72-F4583B2EBD71Q44946402-6A5BD401-B89F-4524-AAE2-77CC46866504Q47688994-3748B5E1-031D-4602-9CC0-E3357F562011
P2860
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@en
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@nl
type
label
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@en
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@nl
prefLabel
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@en
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@nl
P2093
P356
P1433
P1476
Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.
@en
P2093
Brunner GA
Ellmerer M
Siebenhofer A
P2888
P304
P356
10.1007/S001250051618
P577
2001-03-01T00:00:00Z